Sphingolipid metabolism during human platelet activation

Thrombosis Research

Volumn 94, Issue 1, 1999, Pages 13-23

  Simon Jr , Carl G ^a   Gear, Adrian R L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Ceramide; Platelets; Sphingomyelin; Sphingomyelinase

Indexed keywords

SPHINGOMYELIN;

ARTICLE; HUMAN; HUMAN CELL; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; SECOND MESSENGER; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOSIS;

BLOOD PLATELETS; CERAMIDES; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; SPHINGOLIPIDS; SPHINGOMYELINS; THROMBIN;

EID: 0345320407     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00186-8     Document Type: Article

References (47)

1. Siess W. Molecular mechanisms of platelet activation. Physiol Rev. 69:1989;58-178.
2. Gear A.R.L., Burke D. Thrombin-induced secretion of serotonin from platelets can occur in seconds. Blood. 60:1982;1231-1234.
3. Gear A.R.L. Rapid reactions of platelets studied by a quenched-flow approach. Aggregation kinetics J Lab Clin Med. 100:1982;866-886.
4. Yatomi Y., Ruan F., Hakomori S.-i, Igarashi Y. Sphingosine-1-phosphate. A platelet-activating sphingolipid released from agonist-stimulated human platelets Blood. 86:1995;193-202.
5. Yatomi Y., Soichiro Y., Ruan F., Igarashi Y. Sphingosine 1-phosphate induces platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid. J Biol Chem. 272:1997;5291-5297.
6. Hisano N., Yatomi Y., Fujino M.A., Igarashi Y., Kume S., Ozaki Y. Quantification of sphingosine derivatives in human platelets. Inducible formation of free sphingosine J Biochem. 123:1998;263-268.
7. Hannun Y.A. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem. 269:1994;3125-3128.
8. Spiegel S., Milstien S. Sphingolipid metabolites. Members of a new class of lipid second messengers J Mem Biol. 146:1995;225-237.
9. Simon C.G. Jr., Chatterjee S., Gear A.R.L. Sphingomyelinase activity in human platelets. Thromb Res. 90:1998;155-161.
10. Wiegmann K., Schütze S., Machleidt T., Witte D., Krönke M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell. 78:1994;1005-1015.
11. Adam-Klages S., Adam D., Wiegmann K., Struve S., Kolanus W., Schneider-Mergener J., Krönke M. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell. 86:1996;937-947.
12. Santana P., Peña L.A., Haimovitz-Friedman A., Martin S., Green D., Mcloughlin M., Cordon-Cardo C., Schuchman E.H., Fuks Z., Kolesnick R. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell. 86:1996;189-199.
13. Otnaess A.-B., Holm T. The effect of phospholipase C on human blood platelets. J Clin Invest. 57:1976;1419-1425.
14. Chap H.J., Zwaal R.F.A., van Deenen L.L.M. Action of highly purified phospholipase on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane Biochim Biophys Acta. 467:1977;146-164.
15. Jandak J., Li X., Kessimian N., Steiner M. Unequal distribution of membrane components between pseudopodia and cell bodies of platelets. Bioch Biophys Acta. 1029:1990;117-126.
16. Packham M.A., Guccione M.A., Bryant N.L., Livne A. Incorporation of lipids labeled with various fatty acids into the cytoskeleton of aggregating platelets. Lipids. 26:1991;485-491.
17. Mathias S., Dressler K.A., Kolesnick R.N. Characterization of a ceramide-activated protein kinase. Stimulation by tumor necrosis factor α Proc Natl Acad Sci. 88:1991;10009-10013.
18. Müller G., Ayoub M., Storz P., Rennecke J., Fabbro D., Pfizenmaier K. PKC ζ is a molecular switch in signal transduction of TNF-α, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14:1995;1961-1969.
19. Huwiler A., Brunner J., Hummel R., ver Voordeldonk M., Stabel S., van Den Bosch H., Pfeilschifter J. Ceramide-binding and activation defines protein kinase c-raf as a ceramide-activated protein kinase. Proc Natl Acad Sci. 93:1996;6959-6963.
20. Dobrowsky R.T., Hannun Y.A. Ceramide stimulates a cytosolic protein phosphatase. J Biol Chem. 267:1992;5048-5051.
21. Dobrowsky R.T., Kamibayashi C., Mumby M.C., Hannun Y.A. Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem. 268:1993;15523-15530.
22. 2-ceramide. J Biol Chem. 270:1995;12808-12813.
23. Sano K., Takai Y., Yamanashi J., Nishizuka Y. A role of calcium-activated, phospholipid-dependent protein kinase in human platelet activation. J Biol Chem. 258:1982;2010-2013.
24. Geanacopoulos M., Turner J., Bowling K.E., Vandenberg S.R., Gear A.R.L. The role of protein kinase C in the initial events of platelet activation by thrombin assessed with a selective inhibitor. Thromb Res. 69:1993;113-124.
25. Wallace W.C., Bensusan H.B. Protein phosphorylation in platelets stimulated by immobilized thrombin at 37° and 4°C. J Biol Chem. 255:1980;1932-1937.
26. Lerea K.M. Thrombin-induced effects are selectively inhibited following treatment of intact human platelets with okadaic acid. Biochemistry. 30:1991;6819-6824.
27. Walker T.R., Watson S.P. Okadaic acid inhibits activation of phospholipase C in human platelets by mimicking the actions of protein kinases A and C. Br J Pharmacol. 105:1992;627-631.
28. Polanowska-Grabowska R., Simon C.G. Jr., Gear A.R.L. Platelet adhesion to collagen under flow causes dissociation of a phosphoprotein complex of heat-shock proteins and protein phosphatase 1. Blood. 90:1997;1516-1526.
29. van Veldhoven P.P., Mannaerts G.P. Sphinganine 1-phosphate metabolism in cultured skin fibroblasts. Evidence for the existence of a sphingosine phosphatase Biochem J. 299:1994;596-601.
30. Chatterjee S., Ghosh N. Purification of neutral sphingomyelinase from human urine. Methods Enzymol. 197:1991;540-547.
31. Petty A.C., Scrutton M.C. Release of choline metabolites from human platelets. Evidence for activation of phospholipase D and of phosphatidylcholine-specific phospholipase C Platelets. 4:1993;23-29.
32. Tao R.V.P., Sweeley C.C., Jamieson G.A. Sphingolipid composition of human platelets. J Lipid Res. 14:1973;16-25.
33. Chatterjee S., Sweeley C.C. The effect of thrombin induced aggregation on human platelet glycosphingolipids. Biochem Biophys Res Comm. 53:1973;1310-1316.
34. Wang C.-t, Schick P.K. The effect of thrombin on the organization of human platelet membrane glycosphingolipids. J Biol Chem. 256:1981;752-756.
35. Packham M.A., Guccione M.A., Bryant N.L., Livne A. Palmitic acid-labeled lipids selectively incorporated into platelet cytoskeleton during aggregation. Lipids. 25:1990;371-378.
36. Broekman M.J., Ward J.W., Marcus A.J. Phospholipid metabolism in stimulated human platelets. J Clin Invest. 66:1980;275-283.
37. Skeaff C.M., Holub B.J. Altered phospholipid composition of plasma membranes from thrombin-stimulated human platelets. Biochim Biophys Acta. 834:1985;164-171.
38. Skarlatos S.I., Rao R., Dickens B.F., Kruth H.S. Phospholipid loss in dying platelets. Virchows Archiv B Cell Pathol. 64:1993;241-245.
39. Nakashima S., Suganuma A., Matsui A., Nozawa Y. Thrombin induces a biphasic 1,2-diacylglycerol production in human platelets. Biochem J. 275:1991;355-361.
40. Glantz S.A. Primer of Biostatistics, Third Edition. 1992;McGraw-Hill, Inc, New York.
41. Marcus A.J., Ullman H.L., Safier L.B. Lipid composition of subcellular particles of human blood platelets. J Lipid Res. 10:1969;108-114.
42. Krivit W., Hammarström S. Identification and quantitation of free ceramides in human platelets. J Lipid Res. 13:1972;525-530.
43. Kolesnick R.N. Sphingomyelin and derivatives as cellular signals. Prog Lipid Res. 30:1991;1-38.
44. Hashizume T., Kageura T., Sato T. Different effects of cell-permeable ceramide analogs on platelet activation. Bioch Mol Biol Int. 44:1998;489-496.
45. Hannun Y.A., Greenberg C.S., Bell R.M. Sphingosine inhibition of agonist-dependent secretion and activation of human platelets implies that protein kinase C is a necessary and common event of the signal transduction pathways. J Biol Chem. 262:1987;13620-13626.
46. 6-ceramide maintains elevated cytosolic calcium levels in activated platelets. Thromb Res. 81:1996;219-229.
47. 2-ceramide may be responsible for its ability to inhibit platelet aggregation. Biochemistry. 37:1998;2059-2069.